Ulcerative colitis during pregnancy is manageable However timely detection and proper treatment are crucial to ensure a ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's ...

Celltrion plans to generate 20 percent of its annual revenue this year from its original drug Zymfentra as part of its ...

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult ...

Learn why white rice, mashed potatoes, fruits without the skin, and other low-fiber and low-residue foods are your best bet ...

The key Ulcerative Colitis therapies expected to launch in the market include Jyseleca (filgotinib), Rinvoq (Upadacitinib), ...

Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...

The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment ...